Evidence map›Paper›PMID 31273041›Full record

ArticleThe European respiratory journal2019

Plasma mitochondrial DNA is associated with extrapulmonary sarcoidosis.

Changwan Ryu, Caitlin Brandsdorfer, Taylor Adams, Buqu Hu, Dylan W Kelleher, Madeleine Yaggi, Edward P Manning, Anjali Walia, Benjamin Reeves, Hongyi Pan and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The European respiratory journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Derivation of a peripheral blood-based transcriptomic risk score for extrapulmonary sarcoidosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Asthma Risk Gene,Journal of respiratory biology and translational medicine · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Emerging insights in sarcoidosis: moving forward through reverse translational research.American journal of physiology. Lung cellular and molecular physiology · 2022
    Review
  11. Mitochondrial ribosomal stress in lung diseases.American journal of physiology. Lung cellular and molecular physiology · 2022
    Review
  12. Potential biomarkers and targets of mitochondrial dynamics.Clinical and translational medicine · 2021
    Review
  13. Elevated IL-15 concentrations in the sarcoidosis lung are independent of granuloma burden and disease phenotypes.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Changwan RyuSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Caitlin BrandsdorferSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Taylor AdamsSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-4280-9070
Buqu HuSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Dylan W KelleherSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Madeleine YaggiSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Edward P ManningSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-4430-8168
Anjali WaliaSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Benjamin ReevesSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Hongyi PanSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Julia WinklerSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Maksym MinasyanSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Charles S Dela CruzSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Naftali KaminskiSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5917-4601
Mridu GulatiSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Erica L HerzogSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA erica.herzog@yale.edu.
Yale University · US

Funding

Training Translational Lung Biology and PathobiologyT32HL007778 · NHLBI · YALE UNIVERSITY · PI Erica L Herzog, NAFTALI KAMINSKI · 1994 to 2026
$14.4M
Genomic Analysis of Tissue and Cellular Heterogeneity in IPFR01HL127349 · NHLBI · YALE UNIVERSITY · PI BENOS, PANAGIOTIS V, KAMINSKI, NAFTALI · 2015 to 2025
$5.9M
Mir-29 mimicry as a therapy for pulmonary fibrosisUH3HL123886 · NHLBI · YALE UNIVERSITY · PI KAMINSKI, NAFTALI · 2016 to 2018
$4.5M
Novel Immunologic Effects of Semaphorin 7a in IPFR01HL109233 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2011 to 2019
$3.7M
Alveolar DevMAPU01HL122626 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMBALAVANAN, NAMASIVAYAM, HAGOOD, JAMES S. · 2014 to 2018
$3.7M
Neuroimmune Molecules in Scleroderma Lung FibrosisR01HL125850 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2016 to 2019
$1.7M
Mitochondrial DNA and TLR9 in Pulmonary FibrosisK08HL151970 · NHLBI · YALE UNIVERSITY · PI RYU, CHANGWAN · 2020 to 2024
$840k
Significance Circulating Semaphorin 7a+ve Cells in Pulmonary SarcoidosisU01HL112702 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2012 to 2014
$488k
NHLBI NIH HHS K08 HL151970NHLBI NIH HHS R01 HL109233NHLBI NIH HHS R01 HL125850NHLBI NIH HHS R01 HL127349NHLBI NIH HHS T32 HL007778NHLBI NIH HHS U01 HL112702NHLBI NIH HHS U01 HL122626NHLBI NIH HHS UH3 HL123886
6 · The paper itself

Abstract

Sarcoidosis is an unpredictable granulomatous disease in which African Americans disproportionately experience aggressive phenotypes. Mitochondrial DNA (mtDNA) released by cells in response to various stressors contributes to tissue remodelling and inflammation. While extracellular mtDNA has emerged as a biomarker in multiple diseases, its relevance to sarcoidosis remains unknown. We aimed to define an association between extracellular mtDNA and clinical features of sarcoidosis.Extracellular mtDNA concentrations were measured using quantitative PCR for the human

Indexed as

AdultAgedBiomarkersBronchoalveolar LavageBronchoalveolar Lavage FluidCase-Control StudiesDNA, MitochondrialFemaleHEK293 CellsHMGB1 ProteinHumansLungMaleMiddle AgedMitochondrial Proton-Translocating ATPasesPhenotypeBiomarkersDNA, MitochondrialHMGB1 ProteinHMGB1 protein, humanMitochondrial Proton-Translocating ATPasesMT-ATP6 protein, humanTLR9 protein, humanToll-Like Receptor 9

Identifiers

PMID31273041
PMCPMC8088542
OpenAlexW2955682510

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.